The U.S. Food and Drug Administration said it has approved an insulin pump by medical device company Medtronic that automatically manages glucose levels within a target range.
Medtronic said it expects the new product will cost in the range of $6,000 to $9,000 depending on the payer and insurance plan footing the bill, the same price range Medtronic currently charges for its existing pump-and-monitor combo called MiniMed 630G.
Source: FDA Approves Medtronic’s New Automated Insulin Pump – WSJ
Unaffordable? Ripping us off? Oh my‼️ Where’s Bernie and Old Liz❓We need an independent group to evaluate this pricing, right Hillary⁉️ Na, somebody else is footing the bill … but do you have a high deductible health plan?
We can’t control what others do and we can’t stop misfortune from striking. But we can control our own actions. Those who are financially prudent will most likely enjoy success, even if events don’t always go their way.
QUINNSCOMMENTARY 
And this is exactly my problem with medical / drug cost. Why should the price be dependent on “who is footing the bill”? The price should be based on cost + a reasonable profit, not extra for for poor people without insurance or with medicaid and a discount for the rich who have insurance.
LikeLike